Madrigal Pharmaceuticals, Inc. (MDGL)
511.84
-4.90
(-0.95%)
USD |
NASDAQ |
Aug 24, 16:00
511.84
0.00 (0.00%)
After-Hours: 20:00
Madrigal Pharmaceuticals Shareholders Equity (Quarterly) : 523.72M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 523.72M |
| March 31, 2026 | 543.45M |
| December 31, 2025 | 602.69M |
| September 30, 2025 | 625.73M |
| June 30, 2025 | 695.98M |
| March 31, 2025 | 710.64M |
| December 31, 2024 | 754.38M |
| September 30, 2024 | 777.16M |
| June 30, 2024 | 857.12M |
| March 31, 2024 | 850.76M |
| December 31, 2023 | 405.33M |
| September 30, 2023 | 22.25M |
| June 30, 2023 | 103.51M |
| March 31, 2023 | 150.14M |
| December 31, 2022 | 197.39M |
| September 30, 2022 | 10.67M |
| June 30, 2022 | 83.54M |
| March 31, 2022 | 145.74M |
| December 31, 2021 | 196.11M |
| September 30, 2021 | 234.88M |
| June 30, 2021 | 270.65M |
| March 31, 2021 | 260.55M |
| December 31, 2020 | 239.97M |
| September 30, 2020 | 289.70M |
| June 30, 2020 | 342.92M |
| Date | Value |
|---|---|
| March 31, 2020 | 385.48M |
| December 31, 2019 | 416.56M |
| September 30, 2019 | 440.35M |
| June 30, 2019 | 456.99M |
| March 31, 2019 | 468.51M |
| December 31, 2018 | 476.98M |
| September 30, 2018 | 482.91M |
| June 30, 2018 | 486.09M |
| March 31, 2018 | 177.18M |
| December 31, 2017 | 182.26M |
| September 30, 2017 | 54.31M |
| June 30, 2017 | 61.63M |
| March 31, 2017 | 34.45M |
| December 31, 2016 | 36.41M |
| September 30, 2016 | 37.59M |
| June 30, 2016 | 41.57M |
| March 31, 2016 | 44.33M |
| December 31, 2015 | -48.91M |
| September 30, 2015 | 60.37M |
| June 30, 2015 | 68.98M |
| March 31, 2015 | 46.14M |
| December 31, 2014 | 65.14M |
| September 30, 2014 | 83.73M |
| June 30, 2014 | 74.00M |
| March 31, 2014 | 38.22M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Insmed, Inc. | 757.49M |
| PTC Therapeutics, Inc. | -165.36M |
| Protagonist Therapeutics, Inc. | 841.54M |
| Exelixis, Inc. | 1.844B |
| Karyopharm Therapeutics, Inc. | -330.17M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.245B |
| Total Liabilities (Quarterly) | 720.92M |
| Debt to Equity Ratio | 0.664 |
| Current Ratio | 3.205 |
| Net Debt Paydown Yield | -0.37% |